江蘇吳中(600200.SH):響水恆利達收到爆炸事故剩餘賠款1627.21萬元
格隆匯6月30日丨江蘇吳中(600200.SH)公佈,公司全資子公司響水恆利達科技化工有限公司(以下簡稱“響水恆利達”)受“響水3·21爆炸事故”影響,導致部分房屋和門窗損壞,部分員工受傷,目前處於停產狀態。
2019年12月2日,響水恆利達收到中國人民財產保險股份有限公司首筆賠付款人民幣1117.73萬元。
2020年6月30日,響水恆利達收到中國人民財產保險股份有限公司剩餘賠款1627.21萬元。經保險雙方協商一致,涉及保險公司賠償事項現已終結。根據《企業會計準則》的規定,公司收到的本次剩餘保險賠款扣除相關損失後的差額1620.42萬元將計入本報告期營業外收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.